Michael Steffens

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Neural Stem Cells

Clinical Evaluation

Top Venues

The pharmacogenomics journal

Journal of clinical medicine

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Jochen Fracowiak, Tatjana Huebner, Steffen Heß, Christoph Roethlein, Daria Langner, Udo Schneider, Felix Falkenberg, Catharina Scholl, Roland Linder, Julia Carolin Stingl, Britta Haenisch, Michael Steffens
Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes. The pharmacogenomics journal 22 (2) (2022)
Tatjana Huebner, Catharina Scholl, Michael Steffens
Cytogenetic and Biochemical Genetic Techniques for Personalized Drug Therapy in Europe. Diagnostics (Basel, Switzerland) 11 (7) (2021)
Denna Tabari, Catharina Scholl, Michael Steffens, Sandra Weickhardt, Fabian Elgner, Daniela Ploen, Marie-Luise Herrlein, Catarina Sabino, Vesselina Semkova, Michael Peitz, Andreas Till, Oliver Brüstle, Eberhard Hildt, Julia Stingl
Impact of Zika Virus Infection on Human Neural Stem Cell MicroRNA Signatures. Viruses 12 (11) (2020)
Katja Susanne Just, Harald Dormann, Marlen Schurig, Miriam Böhme, Jochen Fracowiak, Michael Steffens, Catharina Scholl, Thomas Seufferlein, Ingo Gräff, Matthias Schwab, Julia C Stingl
Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?-Results from the ADRED Study. Journal of clinical medicine 9 (6) (2020)